AlleleNews -- for in between experiments
Click "Links" to find Product Group Pages on Allele Biotech home
Tuesday, 01.23.2018, 03:12am (GMT-7)
  Home
  Events
  FAQ
  RSS
  Links
  Site Map
  Contact
 
GET TO KNOW YOUR NEIGHBOR ; SDEE 2015 Year End Social on Dec 8th in San Diego ; Must Attend 5-Day Event in San Diego Starting Tomorrow! -- CDW on Cells, Sensors, and Sysems, with Updates on Stem Cells ; SDEE October 2015 Event - Financings: Tales from the Tranches ; Allele Biotech Takes Major Step into Nano Antibody Leadership Position
::| Keyword:       [Advance Search]
 
All News  
  All science fields
  News Release from Allele and Associated Organizations
  Using single cell technologies for functional studies
  Job Postings/Lab Visits/Vendor Shows
  Imaging, Structure, and Optogenetics
  Brain and Neuron Development
  Camelid Antibodies
  FP Technologies and In Vivo Imaging
  iPSC MSC ESC Differentiation
  Immune systems, T cell Therapy, stem cell therapy
  RNA, RNAi, and miRNA Updates
  NexGen Sequencing, Epigenetics, and Editing
  News Release from Other Organizations
  ::| Poll
How do you social? Pick your TOP (#1) pick!
Facebook
Twitter
GooglePlus
WeChat
LinkedIn
Myspace
Youtube
 
  ::| Newsletter
Your Name:
Your Email:
 
 
 
News Release from Allele and Associated Organizations
 
The Beginning of a New Era of Antibodies--Allele Biotech Upgrades Trap to nAb
Wednesday, 10.30.2013, 04:43pm
Last week, Allele Biotech launched a "brand-new" product line, nano antibodies (nAbs, like mAbs for monoclonal antibodies, or pAbs for polyclonal antibodies).  The first products include camelid antibodies against commonly used GFP and the brightest FP mNeonGreen: GFP-nAb and mNeonGreen-nAb.

(shown to the left is quantitative co-precipitation of GFP from cell lysate, with higher capacity than what we used to offer as GFP-Trap).
Allele Biotech Receives NIH Grant to Further Develop mRNA Reprogramming Kits
Wednesday, 06.26.2013, 08:43pm
On June 10, 2013 Allele received an SBIR award from the National Institute of Drug Abuse (NIDA/NIH) entitled “Revolutionary Technology for Efficient Derivation of Human iPSCs with Messenger RNA”.
Allele Biotech Seminar at UCR Dept of Chem Tomorrow
Wednesday, 06.12.2013, 10:59am
Allele's CEO Dr. Jiwu Wang gave a seminar at UCR Department of Chemistry on June 13th, host Prof Huiwang Ai, "mRNA-iPSC, Nanobodies, and the Brightest Monomeric Fluorescent Protein--from a perspective of doing excellent research in a small business setting".
Allele Publishes mNeonGreen as the Brightest Monomeric Fluorescent Protein for Super-resolution Imaging
Saturday, 03.30.2013, 12:00pm
According to Dr. Jiwu Wang, the CEO of Allele Biotechnology, “Super-resolution imaging will become the standard for publication in a short period of time, and mNeonGreen allows researchers to meet this standard while still being compatible with the equipment and methods they already use.”
Allele Biotechnology Initiates Project On Scaled Manufacturing Of Induced Pluripotent Stem Cells And Differentiation
Wednesday, 01.16.2013, 01:38pm
Allele Biotechnology has signed an agreement with Jinan University to develop culturing systems of stem cells and differentiation methods for producing skin tissue cells for wound treatment and stem cell therapy.
Allele Biotechnology Announces New advance in production of human stem cells
Saturday, 09.15.2012, 12:03pm
Through the united efforts of Dr. Warren and the other scientists at Allele Biotechnology, the mRNA reprogramming technique was re-engineered to increase cell conversion efficiency and eliminate any use of potentially unsafe reagents, while substantially reducing the time and effort needed to make stem cells. Dr. Warren believes that because of its advantages this technology “should become the method of choice for iPSC cell banking.”
  » SDEE Quarterly Event: Serial Entrepreneurship--Success and Failure
  » Cheap fluorescent microscope for M. tuberculosis detection
  » Global Climate Change and Entrepreneurial Opportunities in the New Decade
  » Allele Biotech Signed NCI Contract on Finding Synthetic Lethal Targets in Cancer Cells by RNAi
  » House's Appropriations Committee’s health spending subcommittee's 2011 NIH NSF budgets
  » Monomeric Photoconvertible Fluorescent Protein for Imaging of Dynamic Protein Localization
  » Breast Cancer Gene Patents Invalidated
  » Allele Granted Broad Patent on RNAi in China
  » Allele Will Receive Its 3rd US Patent On RNAi
  » Allele Biotech Pre-Announces its Product Line in iPSC Creation Using Baculoviral Vectors


 
  ::| Events
January 2018  
Su Mo Tu We Th Fr Sa
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31      
 
  News in Pictures

High quality histologic services are crucial for determining study outcomes. http://www.allelebiotech.com/histology/

::| Hot News
GET TO KNOW YOUR NEIGHBOR
SDEE 2015 Year End Social on Dec 8th in San Diego
Must Attend 5-Day Event in San Diego Starting Tomorrow! -- CDW on Cells, Sensors, and Sysems, with Updates on Stem Cells
SDEE October 2015 Event - Financings: Tales from the Tranches
WORKSHOP: Advanced Topics in Grant Writing
SDEE Quarterly Event: Tuesday, April 7th, Founder's Tales of Start up to Success—learn from the people who have done it
Allelel Biotech's mRNA iPSC Technology is Licensed by Ocata for Treating Blindness
2014 SDEE SUPPORTING MEMBER YEAR-END SOCIAL
San Diego Entrepreneurs Exchange Quarterly Event-Small Companies Going Global
Allele Biotech Conducts All-RNA CRISPR_cas Genome Editing Development through an NIGMS_NIH SBIR Grant